| Rane Holdings Ltd |
INE384A01010 |
30-Mar-2025 |
Rane Holdings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and year ending March 31 2025. Further in accordance with Ranes lnsider code the Trading window would remain closed for Promoters Directors other connected persons and designated employees of the company from March 31 2025 to June 01 2025 (both days inclusive) for the above purpose. |
| Samrat Pharmachem Ltd |
INE103E01016 |
26-Mar-2025 |
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the financial year ended March 31 2025 |
| Integrated Capital Services Ltd |
INE682B01023 |
31-Mar-2025 |
Integrated Capital Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Approval of Financial Statements for financial year ended 31.03.2025 |
| Procter & Gamble Health Ltd |
INE199A01012 |
26-Mar-2025 |
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 inter alia to consider and approve Audited Financial Statements for the Financial Year ended March 31 2025 and to consider recommendation of dividend (if any). |
| Amara Raja Energy & Mobility Ltd |
INE885A01032 |
31-Mar-2025 |
Amara Raja Energy & Mobility Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Audited financial results for the financial year ended March 31 2025 and recommend final dividend FY25 if any. |
| Sonal Adhesives Ltd |
INE344I01017 |
25-Mar-2025 |
Sonal Adhesives Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Audited Financial Results for the 4th Quarter ended and the year ended 31st March 2025 |
| Insecticides India Ltd |
INE070I01018 |
24-Mar-2025 |
Insecticides (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Meeting of Board of Directors of the Company is scheduled to be held on Wednesday 28th day of May 2025 inter alia to consider and approve the Audited Standalone and Consolidated financial results for the Quarter and Financial year ended March 31 2025.
Pursuant to the Companys Code of Conduct for Prohibition of Insider trading in dealing with securities of the Company and the relevant provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time it is informed that the Trading Window for dealing in securities of Insecticides (India) Limited by Designated Persons and their immediate relatives shall remain closed from April 01 2025 till the end of 48 hours after the declaration of financial results for the quarter and financial year ended March 31 2025. |
| Suven Pharmaceuticals Ltd |
INE03QK01018 |
26-Mar-2025 |
Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the financial results for the period ended March 31 2025 |
| Bosch Ltd |
INE323A01026 |
25-Mar-2025 |
Bosch Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve INTIMATION OF BOARD MEETING SCHEDULED TO BE HELD ON MAY 27 2025 FOR APPROVAL OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDING MARCH 31 2025 AND DECLARATION OF FINAL DIVIDEND IF ANY |
| Procter & Gamble Hygiene and Health Care Ltd |
INE179A01014 |
26-Mar-2025 |
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 27 2025 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended March 312025 and to consider recommendation of dividend if any. |